Limma Diffsplice

limma diffSplice evaluates exon usage within a gene rather than treating the gene’s total expression as the only signal. For each exon, the method compares modeled expression patterns between biological conditions, allowing a subset of exons to appear altered even when the broader gene-level pattern does not change in the same way. This focuses interpretation on transcript regulation.

Linear models provide the statistical framework for representing differences between biological conditions using exon-level expression summaries. They translate the experimental comparison into estimated exon effects that can be assessed consistently across the dataset. This makes the analysis suitable for structured biological comparisons rather than relying on informal inspection of exon measurements alone.

Empirical Bayes moderation improves the variance estimates used when assessing exon-level differences. More reliable variance estimates strengthen the statistical comparison between biological conditions, particularly when exon measurements vary in their precision. Within the limma framework, this moderation helps produce a more stable basis for identifying exons associated with altered splicing patterns.

Exon-level findings become more informative when considered with gene-level evidence, because the gene-level assessment summarizes support across the relevant exon results. This helps distinguish a coherent splicing signal from an isolated exon-level difference. In practice, researchers can use both levels to prioritize candidates whose transcript regulation appears altered between conditions.

Begin with exon-level expression summaries from an RNA-sequencing or microarray experiment organized around the biological conditions of interest. Fit limma linear models to the exon measurements, apply empirical Bayes moderation to the variance estimates, and then assess exon-level differences together with gene-level evidence. The resulting candidates can be prioritized for biological interpretation or follow-up validation.

The method can be applied to exon-level expression summaries generated from RNA-sequencing or microarray data. These summaries must support comparisons between the biological conditions under study, because the models evaluate condition-associated differences in exon usage. Choosing data that preserve exon-level information is therefore central to asking a splicing question rather than only a whole-gene expression question.

It is useful when researchers need to investigate transcript regulation across disease, development, or experimental treatment. By separating altered exon usage from overall gene-expression changes, the analysis can identify candidate transcripts whose splicing patterns differ between conditions. Those candidates provide a statistical basis for functional interpretation and for selecting targets for follow-up validation.